NCT00876083 - PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination | Biotech Hunter

Enrollment

44,920

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Diagnostic Imaging

Interventions

DRUG

Ultravist (Iopromide, BAY86-4877)

Patients with indication for an X-ray examination and for whom the radiologist has decided to use the contrast medium Ultravist.

Trial Locations (21)

Many Locations